A label-free nanopore platform uses programmable DNA circuits to build versatile molecular logic gates, forming a universal basis for scalable DNA computing and advanced biosensing applications.
A new DNA-based therapy could cut cholesterol nearly in half—without relying on statins or causing side effects.